-
In blow for India, S&P affirms negative outlook, reforms key
The rating agency said the main drag on India's rating is a high fiscal deficit and heavy government borrowing, although it also said India's position had improved over the past year. #S&P #India #Manmohan Singh #fiscal deficit #Chidambaram #ExpertView
-
One-in-three chances of India's ratings downgrade next year: S&P
S&P said the government's ability to prop up investment growth remained uncertain. #Standard & Poor's #ExpertView #Negative outlook #credit agency
-
S&P cuts India growth rating to 6% as economy slows
S&P�s growth projection is lower than the government�s estimate of 6.1-6.7%. It is, however, higher than RBI�s projection of 5.7%. #S&P #Economy #India #Slowdown #Growth #ExpertView
-
April WPI inflation lowest since Nov 2009: What Rangarajan, experts have to say
India's headline inflation slowed for a third straight month in April to 4.89 percent, a level seen comfortable for the RBI to persist with monetary easing to revive a flagging economy. Here's what the experts had to say. #C Rangarajan #Wholesale price index #ExpertView #WPI inflation
-
FII ownership of Sensex stocks at 8-year high
During the Jan-March quarter, FIIs were net buyers of Indian equities, while domestic mutual fund companies and state-owned insurer LIC were sellers, it said. #Sensex #Debt #Bank of America Merill Lynch #ExpertView #FII #equities #Foreign Ownership
-
Moody's sees India's sovereign outlook as stable for 18 months
Global rating agency Moody's today said India's sovereign outlook is stable and does not warrant any action on the country's credit rating in the next 12-18 months. #Economy #India #GDP #Moody's #Growth #ExpertView
-
CAD biggest threat to growth: Key highlights of RBI policy
The RBI cut key repo rate by 25 basis point for a third straight time but left the cash reserve ratio unchanged as it looks to bolster an economy growing at a decade low and takes comfort from easing inflation. Here are the key highlights. #Economy #Business #Reserve Bank of India #D. Subbarao #ExpertView #Annual Monetary and Credit Policy 2013-14
-
Launch of patented drugs could be delayed in India. Here's why
The recent government thought process on linking patented drug prices to the country's per-capita income in relation to certain developed markets could result in delayed patented drug entry into India #science #Health #Drugs #ExpertView #Pharma #patents #Deloite
-
Why Unilever may not find many takers for HUL open offer
Several market watchers say investors might be unwilling to part with their shares at the offer price, which could force Unilever to settle for a smaller stake or raise its offer price. #Business #Hindustan Unilever #ExpertView #companies
-
Diversified equity funds do well in April, gold ETFs struggle
India's diversified stock mutual funds outperformed the broader market marginally in April, with high exposure to financial services stocks supporting unit values, data from fund tracker Lipper showed. #Investment #Mutual Funds #BSE #NSE #ExpertView #equities #gold ETF